New endometriosis treatment trial aims to match leading drug

NCT ID NCT07164183

Recruiting now Disease control Sponsor: Alcea Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a new medication called Indinol Forto works as well as an established treatment (Visanne) for reducing pelvic pain caused by endometriosis. Researchers will enroll 290 women aged 18-45 who have been surgically diagnosed with endometriosis and experience moderate to severe pain. Participants will take one of the two medications for 24 weeks while tracking their daily pain levels to see which provides better relief.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Research Site
NOT_YET_RECRUITING

Kazan', Russia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Research Site
NOT_YET_RECRUITING

Moscow, Russia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Research Site
NOT_YET_RECRUITING

Rostov-on-Don, Russia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Research Site
RECRUITING

Ryazan, Russia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Research Site
NOT_YET_RECRUITING

Saint Petersburg, Russia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Research Site
RECRUITING

Smolensk, Russia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Research Site
NOT_YET_RECRUITING

Tver', Russia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Research Site
RECRUITING

Yaroslavl, Russia

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ENDOMETRIOSIS